Regensburg, Germany, March 5, 2020:
Biogents AG, mosquito trap manufacturer, is proud to announce its latest development of a new trap for mosquito monitoring and control: the BG-Pro. Based on a modular concept, it includes Biogents versions of the established EVS (Encephalitis Virus Surveillance) trap and CDC (Centers of Disease Control) light trap, as well as an upgraded version of Biogents’ BG-Sentinel trap. The new product is a recognition of market requests for Biogents to develop other styles of monitoring traps to the same standard as the BG-Sentinel.
After years of being acknowledged as the manufacturer of the BG-Sentinel, the standard tool for Aedes monitoring, Biogents has decided to add its own versions of other standard monitoring tools in the vector management market and therefore to produce its own versions of EVS and CDC type traps. Biogents’ understanding of the monitoring market means the traps are easy to assemble, easy to transport, and easy to use in every type of application.
As with all Biogents products, the BG-Pro has been tested to prove its performance. In studies all over the world, the BG-Pro shows at least comparable performance to the original traps (more information at eu.biogents.com/bg-pro).
The traps are available from our exclusive US distributor Adapco and will be also available from Biogents distributors around the world.
For more information visit eu.biogents.com/bg-pro
-------------------------------
Notes:
Biogents AG
Biogents AG is an innovative company on the forefront of mosquito control research and focuses on the development and production of highly efficient mosquito traps. Biogents traps are the latest innovation in mosquito control traps and incorporate patented technology.
Contact:
Ingeborg Schleip
ingeborg.schleip@biogents.com
Website:
www.eu.biogents.com